Invention Grant
- Patent Title: Pharmaceutical antiretroviral composition
-
Application No.: US15972655Application Date: 2018-05-07
-
Publication No.: US10420727B2Publication Date: 2019-09-24
- Inventor: Geena Malhotra , Shrinivas Purandare
- Applicant: Cipla Limited
- Applicant Address: IN Mumbai
- Assignee: Cipla Limited
- Current Assignee: Cipla Limited
- Current Assignee Address: IN Mumbai
- Agency: Conley Rose, P.C.
- Agent Rodney B. Carroll
- Priority: IN3093/MUM/2012 20121023
- Main IPC: A61K9/20
- IPC: A61K9/20 ; A61K9/22 ; A61K9/26 ; A61K9/24 ; A61K47/00 ; A61K31/535 ; A61K31/505 ; A61K31/415 ; A61K31/473 ; A61K31/513 ; A61K31/52 ; A61K31/5365 ; A61K9/28 ; A61K9/50 ; A61K31/4178 ; A61K31/536 ; A61K45/06 ; A61K9/48 ; A61K31/675

Abstract:
A pharmaceutical composition comprises at least one integrase inhibitor or its salt, solvate, complex, hydrate, isomer, ester, tautomer, anhydrate, enantiomer, polymorph or prodrug and at least one antiretroviral or anti-HIV agent or its salt, solvate, complex, hydrate, isomer, ester, tautomer, anhydrate, enantiomer, polymorph or prodrug.
Public/Granted literature
- US20180250271A1 Pharmaceutical Antiretroviral Composition Public/Granted day:2018-09-06
Information query